| Glucagon-like peptide 1 in health and disease A Andersen, A Lund, FK Knop, T Vilsbøll Nature Reviews Endocrinology 14 (7), 390-403, 2018 | 435 | 2018 |
| Preoperative methylprednisolone enhances recovery after endovascular aortic repair: a randomized, double-blind, placebo-controlled clinical trial L de la Motte, H Kehlet, K Vogt, CH Nielsen, JB Groenvall, HB Nielsen, ... Annals of Surgery 260 (3), 540-549, 2014 | 127 | 2014 |
| Future perspectives on GLP-1 receptor agonists and GLP-1/glucagon receptor co-agonists in the treatment of NAFLD M Seghieri, AS Christensen, A Andersen, A Solini, FK Knop, T Vilsbøll Frontiers in endocrinology 9, 649, 2018 | 89 | 2018 |
| A pharmacological and clinical overview of oral semaglutide for the treatment of type 2 diabetes A Andersen, FK Knop, T Vilsbøll Drugs 81 (9), 1003-1030, 2021 | 63 | 2021 |
| Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases S Hædersdal, A Andersen, FK Knop, T Vilsbøll Nature Reviews Endocrinology 19 (6), 321-335, 2023 | 48 | 2023 |
| Hypoglycaemia and cardiac arrhythmias in diabetes A Andersen, PG Jørgensen, FK Knop, T Vilsbøll Therapeutic Advances in Endocrinology and Metabolism 11, 2042018820911803, 2020 | 38 | 2020 |
| Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls A Andersen, JI Bagger, MPA Baldassarre, MB Christensen, KU Abelin, ... European Journal of Endocrinology 185 (2), 343-353, 2021 | 24 | 2021 |
| Understanding the place for GLP‐1RA therapy: Translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection CR Andreasen, A Andersen, FK Knop, T Vilsbøll Diabetes, Obesity and Metabolism 23, 40-52, 2021 | 23 | 2021 |
| How glucagon-like peptide 1 receptor agonists work CR Andreasen, A Andersen, FK Knop, T Vilsbøll Endocrine Connections 10 (7), R200-R212, 2021 | 22 | 2021 |
| Cardiovascular biomarkers in clinical studies of type 2 diabetes MPA Baldassarre, A Andersen, A Consoli, FK Knop, T Vilsbøll Diabetes, Obesity and Metabolism 20 (6), 1350-1360, 2018 | 22 | 2018 |
| Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study A Andersen, JI Bagger, SK Sørensen, MPA Baldassarre, ... Cardiovascular Diabetology 20 (1), 241, 2021 | 19 | 2021 |
| The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease CR Andreasen, A Andersen, T Vilsbøll Diabetologia 66 (10), 1846-1858, 2023 | 14 | 2023 |
| Glucagon-like peptide 1 receptor agonists for the treatment of Type 2 diabetes A Andersen, AS Christensen, FK Knop, T Vilsbøll Ugeskrift for laeger 181 (12), V10180725-V10180725, 2019 | 8 | 2019 |
| Parenteral nutrition and insulin per protocol improve diabetes management after total pancreatectomy S Andersen, A Andersen, L Ringholm, CP Hansen, J Storkholm, K Lillpers, ... Dan Med J 65 (4), A5475, 2018 | 7 | 2018 |
| Sustained heart rate‐corrected QT prolongation during recovery from hypoglycaemia in people with type 1 diabetes, independently of recovery to hyperglycaemia or euglycaemia CR Andreasen, A Andersen, PG Hagelqvist, K Maytham, JV Lauritsen, ... Diabetes, Obesity and Metabolism 25 (6), 1566-1575, 2023 | 5 | 2023 |
| Glycaemia and cardiac arrhythmias in people with type 1 diabetes: A prospective observational study PG Hagelqvist, A Andersen, K Maytham, CR Andreasen, S Engberg, ... Diabetes, Obesity and Metabolism 25 (8), 2300-2309, 2023 | 4 | 2023 |
| Hypoglycaemia and rebound hyperglycaemia increase left ventricular systolic function in patients with type 1 diabetes CR Andreasen, A Andersen, PG Hagelqvist, JV Lauritsen, PG Jørgensen, ... Diabetes, Obesity and Metabolism 24 (10), 2027-2037, 2022 | 4 | 2022 |
| Exercise‐related hypoglycaemia induces QTc‐interval prolongation in individuals with type 1 diabetes PG Hagelqvist, A Andersen, KB Maytham, CR Andreasen, S Engberg, ... Diabetes, Obesity and Metabolism 25 (5), 1186-1195, 2023 | 3 | 2023 |
| Acute changes in plasma glucose increases left ventricular systolic function in insulin‐treated patients with type 2 diabetes and controls A Andersen, PG Jørgensen, JI Bagger, MPA Baldassarre, MB Christensen, ... Diabetes, Obesity and Metabolism 24 (6), 1123-1131, 2022 | 3 | 2022 |
| Sustained QTc Prolongation During Recovery from Hypoglycemia in People with Type 1 Diabetes, Independently of Recovery to Hyper-or Euglycemia. CR Andreasen, A Andersen, PG Hagelqvist, K Maytham, JV Lauritsen, ... Diabetes, Obesity & Metabolism, 2023 | 2 | 2023 |
